Qian Yao Selected Research

Hypoxia (Hypoxemia)

10/2017	MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression.
1/2016	Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qian Yao Research Topics

Disease

27	Neoplasms (Cancer) 10/2023 - 05/2007
11	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2012
8	Infections 11/2023 - 11/2018
6	Carcinoma (Carcinomatosis) 10/2023 - 08/2013
6	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2012
4	Pancreatitis 01/2023 - 01/2022
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2016
4	Breast Neoplasms (Breast Cancer) 12/2022 - 04/2014
3	Cryptosporidiosis 01/2024 - 05/2021
3	Carcinogenesis 01/2023 - 12/2013
3	Melanoma (Melanoma, Malignant) 01/2022 - 12/2012
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	Major Depressive Disorder (Major Depressive Disorders) 10/2020 - 01/2020
2	Myasthenia Gravis 05/2024 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 01/2023
2	Lymphatic Metastasis 01/2024 - 03/2013
2	Nasopharyngeal Carcinoma 01/2023 - 07/2021
2	Depressive Disorder (Melancholia) 01/2023 - 09/2020
2	Communicable Diseases (Infectious Diseases) 01/2023 - 02/2022
2	Lymphoma (Lymphomas) 10/2022 - 07/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020 - 10/2017
2	Hypoxia (Hypoxemia) 10/2017 - 01/2016
2	Insulin Resistance 10/2016 - 04/2014
2	Necrosis 02/2016 - 03/2009
1	Disease Resistance 01/2024
1	Granuloma 11/2023
1	Disease Progression 10/2023
1	Pulmonary Sarcoidosis 10/2023
1	Shock 10/2023
1	Photosensitivity Disorders (Photodermatitis) 10/2023
1	Primitive Neuroectodermal Tumors (PNET) 08/2023
1	Weight Loss (Weight Reduction) 05/2023
1	Malnutrition (Nutritional Deficiencies) 05/2023
1	Pneumonia (Pneumonitis) 05/2023
1	Diabetes Mellitus 05/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Hemorrhage 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 12/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 07/2023 - 03/2013
6	Biomarkers (Surrogate Marker)IBA 08/2023 - 08/2016
6	Messenger RNA (mRNA)IBA 07/2023 - 03/2013
5	MicroRNAs (MicroRNA)IBA 01/2024 - 04/2014
3	CytokinesIBA 05/2024 - 08/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 04/2016
3	Indicators and Reagents (Reagents)IBA 08/2013 - 03/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2023 - 10/2016
2	antineoplaston A10 (A 10)IBA 10/2023 - 01/2022
2	Circular RNAIBA 07/2023 - 05/2021
2	LipidsIBA 01/2023 - 01/2020
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2023 - 12/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2023
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023 - 07/2021
2	Estrogen ReceptorsIBA 12/2022 - 09/2022
2	Levofloxacin (Levaquin)FDA Link 08/2022 - 01/2022
2	EnzymesIBA 12/2021 - 09/2020
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 06/2015
2	SilverIBA 07/2017 - 01/2016
2	GalaninIBA 10/2016 - 04/2014
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2016 - 04/2014
2	Fluorouracil (Carac)FDA LinkGeneric 04/2016 - 04/2014
2	SOXC Transcription FactorsIBA 06/2015 - 03/2013
2	ChitosanIBA 08/2013 - 05/2007
1	AntibodiesIBA 05/2024
1	StilbenesIBA 01/2024
1	Antimicrobial PeptidesIBA 11/2023
1	CathelicidinsIBA 11/2023
1	Carbon MonoxideIBA 10/2023
1	nitromethaneIBA 10/2023
1	furfuryl alcoholIBA 10/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2023
1	Methylene Blue (Methylthioninium Chloride)FDA Link 10/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2023
1	Contrast MediaIBA 08/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2023
1	3,3',4,5'-tetrahydroxystilbeneIBA 01/2023
1	Beclin-1IBA 01/2023
1	MetalsIBA 01/2023
1	Autophagy-Related ProteinsIBA 01/2023
1	Everolimus FDA Link 01/2023
1	Interleukin-1 (Interleukin 1)IBA 01/2023
1	CeramidesIBA 01/2023
1	Cefotaxime (Kendrick)FDA LinkGeneric 01/2023
1	human ERBB2 proteinIBA 12/2022
1	CateninsIBA 10/2022
1	bufogeninIBA 10/2022
1	Androgen Receptors (Androgen Receptor)IBA 09/2022
1	PolyphenolsIBA 07/2022
1	perfluorooctanesulfonamideIBA 02/2022
1	Long Noncoding RNAIBA 01/2022

Therapy/Procedure

12	Therapeutics 10/2023 - 06/2015
8	Drug Therapy (Chemotherapy) 01/2023 - 12/2013
4	Immunotherapy 12/2022 - 07/2017
2	Neoadjuvant Therapy 10/2023 - 12/2022
2	Combination Drug Therapy (Combination Chemotherapy) 01/2023 - 01/2016
1	Contraindications 01/2024
1	Stents 01/2023
1	Length of Stay 03/2022